GlaxoSmithKline (GSK) is a science-led global healthcare company headquartered in London, UK, with just under 100,000 employees across the world. A leader in the field of pharmaceutical research, development and manufacturing, the firm’s goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.
For several years, GSK has been evaluating a potentially disruptive technology, known as bioelectronics, that could in the future become a whole new class of treatments, complementing traditional drugs. Before allocating resources to take this into mainstream medicine, GSK wanted to make sure they hadn’t missed any angles. So, they appealed to InnoCentive’s global Solver community to identify the best ‘proof of principle’ for these medicines.